No Prescription |
 |
 | ||
|
Lustral Zoloft |
|
| ||
No Prescription » Prescription Drugs 10 » Lustral Zoloft Product Origin: EU (Turkey)This product is able to be sourced and supplied at excellent prices because of favourable cross border currency conversions. All products are authentic brand names and will include a product information insert in English.Medical Information:Sertraline is indicated for the treatment of major depressive disorder in adults.Sertraline is used for: Treating depression obsessive-compulsive disorder (OCD) panic disorder posttraumatic stress disorder (PTSD) premenstrual dysphoric disorder (PMDD; a severe form of premenstrual syndrome) and social anxiety disorder. Sertraline is an antidepressant in a group of drugs called selective serotonin reuptake inhibitors (SSRIs). Sertraline affects chemicals in the brain that may become unbalanced and cause depression panic anxiety or obsessive-compulsive symptoms.Sertraline is used to treat depression obsessive-compulsive disorder panic disorder anxiety disorders post-traumatic stress disorder (PTSD) and premenstrual dysphoric disorder (PMDD).Sertraline is prescribed for major depression--a persistently low mood that interferes with everyday living. Symptoms may include loss of interest in your usual activities disturbed sleep change in appetite constant fidgeting or lethargic movement fatigue feelings of worthlessness or guilt difficulty thinking or concentrating and recurrent thoughts of suicide.Sertraline is also used to treat the following:Premenstrual dysphoric disorder (PMDD) a condition marked by a depressed mood anxiety or tension emotional instability and anger or irritability in the two weeks preceding menstruation. Obsessive-compulsive disorder (unwanted thoughts that won't go away and an irresistible urge to keep repeating certain actions such as hand-washing or counting). Panic disorder (unexpected attacks of overwhelming anxiety accompanied by fear of their return). Social anxiety disorder (extreme shyness in social situations that interferes with an individual's work and social life). Post-traumatic stress disorder (re-experiencing a dangerous or life-threatening event through intrusive thoughts flashbacks and intense psychological distress). Sertraline belongs to a class of drugs called selective serotonin re-uptake inhibitors (SSRIs). Serotonin is one of the chemical messengers believed to govern moods. Ordinarily it is quickly reabsorbed after its release at the junctures between nerves. Re-uptake inhibitors such as Sertraline slow this process thereby boosting the levels of serotonin available in the brain.. Buy Lustral Zoloft and other Prescription Drugs 10 products online at Medstore. 3692
About Lustral Zoloft: Product Type: Prescription Drugs 10 Lustral ( Zoloft Seralin Generic Sertraline ) Lustral (Zoloft Seralin Generic Sertraline) Zoloft Seralin Generic Sertraline 50mg 28 Tablets Zoloft Seralin Generic Sertraline Lustral
View more Prescription Drugs 10 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
